Biao Wang, et al. v. Zymergen Inc., et al.

District Court, N.D. California·Decided June 22, 2026·No. 5:21-cv-06028·Unknown

Opinion

BIAO WANG, et al., Case No. 21-cv-06028-PCP

Plaintiffs, ORDER GRANTING MOTION FOR v. PRELIMINARY APPROVAL OF CLASS-ACTION SETTLEMENT ZYMERGEN INC., et al., Re: Dkt. No. 646 Defendants.

In this securities-fraud class action, lead plaintiff Biao Wang represents a class of investors in Zymergen, Inc’s initial public offering in 2021. Wang asserts that Zymergen’s registration statements contained misleading or untrue statements concerning the company’s product- development pipeline and expected revenue generation or omitted material facts about Zymergen’s business projections. The initial complaint in this action was filed on August 4, 2021. The operative second amended complaint (SAC), which was filed on March 4, 2024, asserts claims under Sections 11 and 15 of the Securities Act, 15 U.S.C. §§ 77k and 77o, against various individuals and entities that allegedly exercised control over Zymergen or were otherwise involved in the alleged securities fraud. The Court granted in part and denied in part the motions to dismiss the SAC on August 14, 2024, allowing the § 11 claims to proceed in full and allowing the § 15 claims to proceed except as to a subset of defendant entities. On August 11, 2023, the Court certified a class consisting of persons and entities that purchase or otherwise acquired Zymergen common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with Zymergen’s IPO. Thereafter, notice was sent to over 9,200 potential class members and nominees, and no potential 2025, the parties engaged in extensive fact discovery, including Wang’s deposition of six fact witnesses and defendants’ depositions of the plaintiffs. Following the close of fact discovery, the parties exchanged expert reports and engaged in expert discovery from January to May 2025, with Wang serving reports from a total of four experts and defendants serving reports from five. The parties also engaged in a lengthy mediation process over the course of more than two years before former United States District Judge Layn R. Phillips. After the culmination of that process, the parties informed the Court on November 25, 2025 that they had reached a settlement in principle based on the mediator’s proposal. On March 25, 2026, the parties moved for preliminary approval of the class-action settlement, approval of the class notice program, approval of the settlement administrator, and the setting of a final approval hearing. The Court heard argument on the motion on April 30, 2026. Under the terms of the settlement, the settling defendants will pay, or cause to be paid, $125 million into a settlement fund, which will first cover the costs of administering the settlement, providing notice to class members, funding class representative awards, paying any award of attorneys’ fees and costs (including interest) to plaintiffs’ counsel, and paying any taxes or tax-related expenses, and then be distributed pro rata to class members who submit valid and timely claims. The class representatives may seek awards pursuant to 15 U.S.C. §77z-1(a)(4) of no more than $40,000 in the aggregate. Plaintiffs’ counsel will seek fees of no more than 30% of the settlement amount and expenses of up to $3 million. Under the terms of the settlement, class members will release “all claims and causes of action … that have been or could have been asserted in [this action], … [and are] based on, arising out of, or in connection with both: (i) the purchase, acquisition, holding, sale, or disposition of Zymergen common stock purchased or acquired pursuant and/or traceable to the Registration Statement; and (ii) the allegations, acts, transactions, facts, events, matters, occurrences, disclosures, filings, representations, statements, or omissions that were or could have been alleged by Lead Plaintiff or other Class Members in [this action].” The parties propose notifying class members by sending a summary notice by email or service, and placing the notice on a dedicated, publicly accessible settlement website with detailed information on the proposed settlement. Under the proposed schedule, settlement administrator Verita will begin providing notice to class members within 21 days of this preliminary approval order. Class members will have at least 90 days from the date of preliminary approval to object to the settlement. Verita estimates the cost of providing notice and administering the settlement at $700,000, approximately half of one percent of the settlement fund. While “[t]he Ninth Circuit has a strong judicial policy that favors settlements in class actions,” Hudson v. Libre Technology, Inc., 2019 WL 5963648, at *3 (S.D. Cal. Nov. 13, 2019), Federal Rule of Civil Procedure 23(e) nevertheless requires that district courts approve any class- action settlement. That is because “settlement class actions present unique due process concerns for absent class members, and the district court has a fiduciary duty to look after the interests of those absent class members.” Allen v. Bedolla, 787 F.3d 1218, 1223 (9th Cir. 2015) (citation modified). To protect those interests, “courts must scrutinize settlement agreements—including post-class certification settlements—for potentially unfair collusion” between the defendants and class counsel. Briseño v. Henderson, 998 F.3d 1014, 1019 (9th Cir. 2021). “Approval of a settlement is a two-step process. Courts first determine whether a proposed class action settlement deserves preliminary approval and then, after notice is given to class members, whether final approval is warranted.” In re Volkswagen “Clean Diesel” Mktg., Sales Pracs., & Prod. Liab. Litig., 229 F. Supp. 3d 1052, 1062 (N.D. Cal. 2017) (quoting In re High- Tech Employee Antitrust Litig., 2014 WL 3917126, at *3 (N.D. Cal. Aug. 8, 2014)). A settlement deserves preliminary approval where the Court “will likely be able to … approve the proposal under Rule 23(e)(2)” and “certify the class for purposes of judgment on the proposal.” Fed. R. Civ. P. 23(e)(1)(B). As to likely approval, Rule 23(e)(2) requires district courts to ensure that any class settlement is “fair, reasonable, and adequate.” Fed. R. Civ. Proc. 23(e)(2). In making this determination, a court must consider whether: (A) the class representatives and class counsel have adequately represented the class; (B) the proposal was negotiated at arm’s length; (C) the relief provided for the class is adequate, taking into account: (i) the costs, risks, and delay of trial and appeal; (ii) the effectiveness of any proposed method of distributing relief to the class, including the method of processing class- member claims; (iii) the terms of any proposed award of attorney’s fees, including timing of payment; and (iv) any agreement required to be identified under Rule 23(e)(3); and (D) the proposal treats class members equitably relative to each other. Id. ANALYSIS I. The proposed settlement is fair, reasonable, and adequate. Because the Court has already certified a plaintiff class in this action, it need only consider whether it will likely approve the proposed settlement—that is, whether the proposed settlement is likely “fair, reasonab

Free access — add to your briefcase to read the full text and ask questions with AI

Biao Wang, et al. v. Zymergen Inc., et al., (N.D. Cal. 2026).

Biao Wang, et al. v. Zymergen Inc., et al. (Biao Wang, et al. v. Zymergen Inc., et al.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Rodriguez v. West Publishing Corp.
563 F.3d 948 (Ninth Circuit, 2009)
In Re Tableware Antitrust Litigation
484 F. Supp. 2d 1078 (N.D. California, 2007)
Margie Bedolla v. Labor Ready Southwest, Inc.
787 F.3d 1218 (Ninth Circuit, 2015)
Sherri B. Simpson v. Trump University, LLC
881 F.3d 1111 (Ninth Circuit, 2018)
Robert Briseno v. Conagra Foods, Inc.
998 F.3d 1014 (Ninth Circuit, 2021)
Low v. Trump University, LLC
246 F. Supp. 3d 1295 (S.D. California, 2017)
McFadden v. Ballard, Spahr, Andrews, & Ingersoll, LLP
243 F.R.D. 1 (District of Columbia, 2007)